UBS AM
CRMD icon

UBS AM’s CorMedix CRMD Stock Holding History

UBS AM’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.17M Buy
171,882
+61,596
+56% +$455K ﹤0.01% 2286
2025
Q4 		$1.28M Sell
110,286
-6,538
-6% -$72.3K ﹤0.01% 2055
2025
Q3 		$1.36M Sell
116,824
-73,018
-38% -$883K ﹤0.01% 1897
2025
Q2 		$2.34M Buy
189,842
+84,166
+80% +$929K ﹤0.01% 2079
2025
Q1 		$651K Buy
+105,676
New +$1.09M ﹤0.01% 2440

Other funds holding CRMD

DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.3B AUM 33.54% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM